Ionis Pharmaceuticals (IONS) PT Lowered to $55 at BofA Securities
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $60.29 -0.12%
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
BofA Securities analyst Jason Gerberry lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $55.00 (from $56.00) while maintaining a Buy rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Petroleo Brasileiro SA (PETR4:BZ) (PBR) PT Raised to R$58.50 at JPMorgan
- Comstock Resources (CRK) PT Raised to $20 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
